Design, Synthesis, Biological Activity and Molecular Dynamics Studies of Specific Protein Tyrosine Phosphatase 1B Inhibitors over SHP-2

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2013 Jun 19

PMID 23774838

Citations 3

Authors

Su-Xia Sun

Xiao-Bo Li

Wen-Bo Liu

Ying Ma

Run-Ling Wang

Xian-Chao Cheng

Shu-Qing Wang

Wei Liu

Affiliations

Soon will be listed here.

Abstract

Over expressing in PTPN1 (encoding Protein tyrosine phosphatase 1B, PTP1B), a protein tyrosine phosphatase (PTP) that plays an overall positive role in insulin signaling, is linked to the pathogenesis of diabetes and obesity. The relationship between PTP1B and human diseases exhibits PTP1B as the target to treat these diseases. In this article, small weight molecules of the imidazolidine series were screened from databases and optimized on silicon as the inhibitors of PTP1B based on the steric conformation and electronic configuration of thiazolidinedione (TZD) compounds. The top three candidates were tested using an in vitro biological assay after synthesis. Finally, we report a novel inhibitor, Compound 13, that specifically inhibits PTP1B over the closely related phosphatase Src homology 2 (SH2) domain-containing phosphatase 2 (SHP-2) at 80 μΜ. Its IC50 values are reported in this paper as well. This compound was further verified by computer analysis for its ability to combine the catalytic domains of PTP1B and SHP-2 by molecular dynamics (MD) simulations.

Citing Articles

Small Molecule Inhibitor that Stabilizes the Autoinhibited Conformation of the Oncogenic Tyrosine Phosphatase SHP2.

Wu X, Xu G, Li X, Xu W, Li Q, Liu W J Med Chem. 2018; 62(3):1125-1137.

PMID: 30457860 PMC: 6467801. DOI: 10.1021/acs.jmedchem.8b00513.

Structure based design, synthesis and activity studies of small hybrid molecules as HDAC and G9a dual inhibitors.

Zang L, Kondengaden S, Zhang Q, Li X, Sigalapalli D, Kondengadan S Oncotarget. 2017; 8(38):63187-63207.

PMID: 28968981 PMC: 5609913. DOI: 10.18632/oncotarget.18730.

Antiobesity and Antidiabetes Effects of a Cudrania tricuspidata Hydrophilic Extract Presenting PTP1B Inhibitory Potential.

Kim D, Lee S, Chung Y, Kim B, Kim H, Kim K Biomed Res Int. 2016; 2016:8432759.

PMID: 26989693 PMC: 4775776. DOI: 10.1155/2016/8432759.

References

Zhang W, Hong D, Zhou Y, Zhang Y, Shen Q, Li J . Ursolic acid and its derivative inhibit protein tyrosine phosphatase 1B, enhancing insulin receptor phosphorylation and stimulating glucose uptake. Biochim Biophys Acta. 2006; 1760(10):1505-12. DOI: 10.1016/j.bbagen.2006.05.009. View

Wang J, Gong K, Wei D, Li Y, Chou K . Molecular dynamics studies on the interactions of PTP1B with inhibitors: from the first phosphate-binding site to the second one. Protein Eng Des Sel. 2009; 22(6):349-55. DOI: 10.1093/protein/gzp012. View

Li X, Wang S, Xu W, Wang R, Chou K . Novel inhibitor design for hemagglutinin against H1N1 influenza virus by core hopping method. PLoS One. 2011; 6(11):e28111. PMC: 3227604. DOI: 10.1371/journal.pone.0028111. View

Loh M, Vattikuti S, Schubbert S, Reynolds M, Carlson E, Lieuw K . Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis. Blood. 2003; 103(6):2325-31. DOI: 10.1182/blood-2003-09-3287. View

Friesner R, Banks J, Murphy R, Halgren T, Klicic J, Mainz D . Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem. 2004; 47(7):1739-49. DOI: 10.1021/jm0306430. View

Irwin J, Shoichet B . ZINC--a free database of commercially available compounds for virtual screening. J Chem Inf Model. 2005; 45(1):177-82. PMC: 1360656. DOI: 10.1021/ci049714+. View

Berman H, Battistuz T, Bhat T, Bluhm W, Bourne P, Burkhardt K . The Protein Data Bank. Acta Crystallogr D Biol Crystallogr. 2002; 58(Pt 6 No 1):899-907. DOI: 10.1107/s0907444902003451. View

Qu C . Role of the SHP-2 tyrosine phosphatase in cytokine-induced signaling and cellular response. Biochim Biophys Acta. 2002; 1592(3):297-301. DOI: 10.1016/s0167-4889(02)00322-1. View

Bentires-Alj M, Paez J, David F, Keilhack H, Halmos B, Naoki K . Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia. Cancer Res. 2004; 64(24):8816-20. DOI: 10.1158/0008-5472.CAN-04-1923. View

10.

Hellmuth K, Grosskopf S, Lum C, Wurtele M, Roder N, von Kries J . Specific inhibitors of the protein tyrosine phosphatase Shp2 identified by high-throughput docking. Proc Natl Acad Sci U S A. 2008; 105(20):7275-80. PMC: 2438240. DOI: 10.1073/pnas.0710468105. View

11.

Vella A, de Groen P, Dinneen S . Fatal hepatotoxicity associated with troglitazone. Ann Intern Med. 1998; 129(12):1080. DOI: 10.7326/0003-4819-129-12-199812150-00032. View

12.

Zhang X, He Y, Liu S, Yu Z, Jiang Z, Yang Z . Salicylic acid based small molecule inhibitor for the oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2). J Med Chem. 2010; 53(6):2482-93. PMC: 2842125. DOI: 10.1021/jm901645u. View

13.

Halgren T, Murphy R, Friesner R, Beard H, Frye L, Pollard W . Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem. 2004; 47(7):1750-9. DOI: 10.1021/jm030644s. View

14.

Pei Z, Li X, Liu G, Abad-Zapatero C, Lubben T, Zhang T . Discovery and SAR of novel, potent and selective protein tyrosine phosphatase 1B inhibitors. Bioorg Med Chem Lett. 2003; 13(19):3129-32. DOI: 10.1016/s0960-894x(03)00725-x. View

15.

Oostenbrink C, Soares T, van der Vegt N, van Gunsteren W . Validation of the 53A6 GROMOS force field. Eur Biophys J. 2005; 34(4):273-84. DOI: 10.1007/s00249-004-0448-6. View

16.

Zhang S, Zhang Z . PTP1B as a drug target: recent developments in PTP1B inhibitor discovery. Drug Discov Today. 2007; 12(9-10):373-81. DOI: 10.1016/j.drudis.2007.03.011. View

17.

Barford D, Flint A, Tonks N . Crystal structure of human protein tyrosine phosphatase 1B. Science. 1994; 263(5152):1397-404. View

18.

Schuttelkopf A, van Aalten D . PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr D Biol Crystallogr. 2004; 60(Pt 8):1355-63. DOI: 10.1107/S0907444904011679. View

19.

Yu W, Guvench O, MacKerell A, Qu C . Identification of small molecular weight inhibitors of Src homology 2 domain-containing tyrosine phosphatase 2 (SHP-2) via in silico database screening combined with experimental assay. J Med Chem. 2008; 51(23):7396-404. PMC: 2645921. DOI: 10.1021/jm800229d. View

20.

Zinker B, Rondinone C, Trevillyan J, Gum R, Clampit J, Waring J . PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice. Proc Natl Acad Sci U S A. 2002; 99(17):11357-62. PMC: 123261. DOI: 10.1073/pnas.142298199. View